Development Level

Tbio 33 | 11,445
Tdark 10 | 6,588
Tchem 1 | 1,598

IMPC Phenotype

increased circulating HDL chol... 2 | 80
increased circulating choleste... 2 | 66
increased neutrophil cell numb... 2 | 46
abnormal behavior 1 | 298
abnormal eye size 1 | 7
abnormal retina morphology 1 | 71
decreased circulating calcium ... 1 | 36
decreased circulating chloride... 1 | 30
decreased grip strength 1 | 116
decreased lean body mass 1 | 135
decreased vertical activity 1 | 208
improved glucose tolerance 1 | 79
increased body length 1 | 32
increased bone mineral content 1 | 108
increased circulating creatini... 1 | 38
increased circulating phosphat... 1 | 26
increased heart weight 1 | 62
increased or absent threshold ... 1 | 101
increased red blood cell distr... 1 | 34
increased spleen weight 1 | 10
preweaning lethality, complete... 1 | 979
short tibia 1 | 97
thrombocytopenia 1 | 56

Disease

Carcinoma 30 | 11,493
glioblastoma 22 | 5,792
ovarian cancer 20 | 8,520
osteosarcoma 19 | 7,950
lung cancer 18 | 4,740
medulloblastoma, large-cell 18 | 6,241
ependymoma 17 | 4,679
adult high grade glioma 16 | 3,801
atypical teratoid / rhabdoid tumor 16 | 5,112
psoriasis 16 | 6,694
Astrocytoma, Pilocytic 14 | 3,081
invasive ductal carcinoma 12 | 2,951
Breast cancer 11 | 3,578
Cancer 11 | 2,499
astrocytic glioma 11 | 2,597
oligodendroglioma 11 | 2,850
breast carcinoma 10 | 1,638
intraductal papillary-mucinous adenoma (IPMA) 10 | 2,955
lung carcinoma 10 | 2,843
pancreatic cancer 10 | 2,398
group 3 medulloblastoma 9 | 4,104
intraductal papillary-mucinous carcinoma (IPMC) 9 | 2,989
intraductal papillary-mucinous neoplasm (IPMN) 9 | 3,291
malignant mesothelioma 9 | 3,232
non-small cell lung cancer 9 | 2,890
subependymal giant cell astrocytoma 9 | 2,287
ulcerative colitis 8 | 1,819
Kidney cancer 7 | 2,613
colon cancer 7 | 1,478
cystic fibrosis 7 | 1,696
diabetes mellitus 7 | 1,728
lung adenocarcinoma 7 | 2,716
pituitary cancer 7 | 1,972
adrenocortical carcinoma 6 | 1,428
group 4 medulloblastoma 6 | 1,855
interstitial cystitis 6 | 2,312
juvenile dermatomyositis 6 | 1,187
primary pancreatic ductal adenocarcinoma 6 | 1,109
Duchenne muscular dystrophy 5 | 601
Liver Cirrhosis, Experimental 5 | 769
ductal carcinoma in situ 5 | 1,745
primitive neuroectodermal tumor 5 | 3,035
tuberculosis 5 | 2,010
Atherosclerosis 4 | 291
Atopic dermatitis 4 | 952
Autosomal recessive predisposition 4 | 1,442
Schizophrenia 4 | 1,160
autosomal dominant Emery-Dreifuss muscular dystrophy 4 | 510
gastric carcinoma 4 | 807
non primary Sjogren syndrome sicca 4 | 891
pancreatic ductal adenocarcinoma liver metastasis 4 | 1,962
Degenerative disc disease 3 | 35
Dermatitis, Allergic Contact 3 | 67
Down syndrome 3 | 499
Hypertensive disease 3 | 292
Liver diseases 3 | 87
Osteoarthritis 3 | 184
active ulcerative colitis 3 | 764
aldosterone-producing adenoma 3 | 665
cutaneous lupus erythematosus 3 | 1,057
head and neck cancer 3 | 271
limb girdle muscular dystrophy 2A 3 | 213
medulloblastoma 3 | 720
nasopharyngeal carcinoma 3 | 1,058
pediatric high grade glioma 3 | 1,064
urothelial carcinoma 3 | 318
Alzheimer's disease 2 | 658
Arthritis 2 | 290
Asthma 2 | 385
Cerebrovascular disease 2 | 238
Congenital Bilateral Cataracts 2 | 50
Congenital cataract 2 | 50
Dizziness 2 | 26
Endometrial Neoplasms 2 | 55
Heart disease 2 | 306
Highly variable severity 2 | 157
Hyperhidrosis disorder 2 | 81
Hypertension 2 | 396
Increased sweating 2 | 81
Liver cancer 2 | 604
Multiple Sclerosis 2 | 540
Multiple myeloma 2 | 1,332
Myocardial Ischemia 2 | 169
Myopia 2 | 176
Nausea and vomiting 2 | 97
Pick disease 2 | 1,894
Polycystic ovary syndrome 2 | 360
Sensorineural Hearing Loss (disorder) 2 | 284
Sweating 2 | 81
Tinnitus 2 | 19
Variable expressivity 2 | 157
Vascular disease 2 | 319
Vertigo 2 | 29
X-linked cerebral adrenoleukodystrophy 2 | 116
acute quadriplegic myopathy 2 | 1,158
dermatomyositis 2 | 966
pancreatic carcinoma 2 | 562
posterior fossa group A ependymoma 2 | 468
pterygium 2 | 76
sonic hedgehog group medulloblastoma 2 | 467

Tissue

Endocrine System 44 | 18,159
Digestive Tract 42 | 17,369
Female tissues 42 | 17,400
Nervous System 42 | 16,725
Liver and Pancreas 41 | 16,750
Male tissues 41 | 17,142
Skin and soft tissues 41 | 17,230
Urinary Tract 41 | 16,678
Blood and immune system 39 | 16,909
Cardiovascular System 39 | 15,192
Respiratory system 39 | 16,393

Target Family

Non-IDG 41 | 12,091
Enzyme 2 | 4,145
Transcription Factor 1 | 1,400

GO Process

negative regulation of JAK-STA... 44 | 44
transcription, DNA-templated 1,742 | 1,742
regulation of transcription, D... 1,135 | 1,135
G-protein coupled receptor sig... 1,053 | 1,053
signal transduction 1,005 | 1,005
positive regulation of transcr... 932 | 932
negative regulation of transcr... 683 | 683
positive regulation of transcr... 529 | 529
apoptotic process 511 | 511
cell differentiation 511 | 511
negative regulation of transcr... 492 | 492
neutrophil degranulation 484 | 484
negative regulation of apoptot... 479 | 479
positive regulation of cell pr... 470 | 470
innate immune response 469 | 469
multicellular organism develop... 460 | 460
cell adhesion 458 | 458
immune response 426 | 426
viral process 405 | 405
negative regulation of cell pr... 398 | 398
spermatogenesis 389 | 389
intracellular signal transduct... 376 | 376
inflammatory response 373 | 373
cell proliferation 366 | 366
post-translational protein mod... 356 | 356
protein transport 348 | 348
protein ubiquitination 347 | 347
cell division 345 | 345
regulation of transcription fr... 345 | 345
protein phosphorylation 334 | 334
nervous system development 321 | 321
positive regulation of apoptot... 320 | 320
response to drug 303 | 303
cell-cell signaling 300 | 300
positive regulation of gene ex... 297 | 297
transcription from RNA polymer... 286 | 286
protein deubiquitination 271 | 271
cell cycle 268 | 268
regulation of immune response 259 | 259
transport 255 | 255
regulation of apoptotic proces... 250 | 250
MAPK cascade 242 | 242
cell surface receptor signalin... 239 | 239
mRNA splicing, via spliceosome 236 | 236
protein polyubiquitination 222 | 222
angiogenesis 220 | 220
chemical synaptic transmission 219 | 219
cellular response to DNA damag... 217 | 217
proteolysis 217 | 217
proteasome-mediated ubiquitin-... 210 | 210
adaptive immune response 209 | 209
intracellular protein transpor... 209 | 209
DNA repair 206 | 206
leukocyte migration 206 | 206
protein homooligomerization 206 | 206
rRNA processing 204 | 204
extracellular matrix organizat... 198 | 198
visual perception 198 | 198
positive regulation of ERK1 an... 194 | 194
cellular protein metabolic pro... 192 | 192
brain development 188 | 188
axon guidance 186 | 186
Fc-epsilon receptor signaling ... 182 | 182
keratinization 182 | 182
cell migration 181 | 181
defense response to virus 181 | 181
positive regulation of cell mi... 179 | 179
regulation of cell proliferati... 177 | 177
in utero embryonic development 176 | 176
Wnt signaling pathway 175 | 175
cilium assembly 175 | 175
blood coagulation 170 | 170
RNA splicing 169 | 169
translation 169 | 169
mRNA processing 168 | 168
protein autophosphorylation 168 | 168
aging 167 | 167
response to hypoxia 166 | 166
T cell receptor signaling path... 164 | 164
heart development 164 | 164
negative regulation of canonic... 164 | 164
positive regulation of I-kappa... 164 | 164
ubiquitin-dependent protein ca... 164 | 164
ER to Golgi vesicle-mediated t... 162 | 162
protein stabilization 160 | 160
response to lipopolysaccharide 160 | 160
transcription initiation from ... 160 | 160
defense response to bacterium 159 | 159
protein folding 159 | 159
sensory perception of smell 157 | 157
homophilic cell adhesion via p... 156 | 156
transmembrane transport 154 | 154
negative regulation of gene ex... 151 | 151
interferon-gamma-mediated sign... 150 | 150
receptor-mediated endocytosis 150 | 150
ion transmembrane transport 148 | 148
peptidyl-serine phosphorylatio... 148 | 148
positive regulation of protein... 148 | 148
antigen processing and present... 143 | 143
DNA replication 142 | 142
cell cycle arrest 142 | 142

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Chondroadherin CHAD Tbio Non-IDG -1.99536 100.3 73
Suppressor of cytokine signaling 2 SOCS2 Tbio Non-IDG -2.90841 804.7 196
Disabled homolog 1 DAB1 Tbio Non-IDG -0.36015 2.98 395
Reticulon-4 receptor RTN4R Tbio Non-IDG -2.60200 411.8 232
Merlin NF2 Tbio Non-IDG -3.17301 1540.0 457